;
Skip to main content
Home > Week in Review > Offerings

Chronological Index of : Financial News

 Current Issue
  • Aerie Pharmaceuticals proposes private placement of senior convertible notes

    Aerie Pharmaceuticals Inc. (NASDAQ:AERI), Bedminster, N.J. Business: Ophthalmic Date announced: 2014-09-09 Type: Private placement of senior convertible notes To be raised: $125 million Shares: TBD Price: TBD Shares …

    Published on 9/15/2014
  • Kolltan proposes IPO

    Kolltan Pharmaceuticals Inc., New Haven, Conn. Business: Cancer, Antibodies Date announced: 2014-09-12 Type: IPO To be raised: Up to $86.3 million Shares: TBD Price: TBD Underwriters: Leerink Partners; Stifel, Nicolaus;…

    Published on 9/15/2014
  • PRA Health Sciences proposes IPO

    PRA Health Sciences Inc., Raleigh, N.C. Business: Supply/Service Date announced: 2014-09-08 Type: IPO To be raised: Up to $375 million Shares: TBD Price: TBD Underwriters: Jefferies; Citigroup; KKR Capital Markets; UBS;…

    Published on 9/15/2014
  • Virobay proposes IPO

    Virobay Inc., Menlo Park, Calif. Business: Autoimmune, Neurology, Hepatic Date announced: 2014-09-10 Type: IPO To be raised: Up to $50 million Shares: TBD Price: TBD Underwriters: Piper Jaffray; JMP Securities; Cantor …

    Published on 9/15/2014
  • Xenon proposes IPO

    Xenon Pharmaceuticals Inc., Burnaby, B.C. Business: Pharmacogenetics, Neurology, Endocrine/Metabolic Date announced: 2014-09-10 Type: IPO To be raised: Up to $51.8 million Shares: TBD Price: TBD Underwriters: Jefferies;…

    Published on 9/15/2014
  • Affimed Therapeutics amends IPO

    Affimed Therapeutics B.V., Heidelberg, Germany Business: Cancer, Inflammation, Antibodies Date announced: 2014-09-02 Type: IPO To be raised: Up to $81.3 million Shares: 6.3 million Price: $11-$13 Underwriters: Jefferies…

    Published on 9/8/2014
  • Foamix amends IPO

    Foamix Ltd., Ness Ziona, Israel Business: Drug delivery Date announced: 2014-09-03 Type: IPO To be raised: Up to $70.9 million Shares: 5.9 million Price: $10-$12 Underwriters: Barclays Capital; Cowen; Oppenheimer; Maxim…

    Published on 9/8/2014
  • rEVO Biologics amends IPO

    rEVO Biologics Inc., Framingham, Mass. Business: Hematology Date announced: 2014-09-04 Type: IPO To be raised: Up to $54 million Shares: 3.6 million Price: $13-$15 Underwriters: Piper Jaffray; Guggenheim Securities; …

    Published on 9/8/2014
  • Tokai amends IPO

    Tokai Pharmaceuticals Inc., Cambridge, Mass. Business: Cancer Date announced: 2014-09-02 Type: IPO To be raised: Up to $81 million Shares: 5.4 million Price: $13-$15 Underwriters: BMO Capital Markets; Stifel, Nicolaus; …

    Published on 9/8/2014
  • Viking Therapeutics amends IPO

    Viking Therapeutics Inc., San Diego, Calif. Business: Endocrine/Metabolic, Musculoskeletal, Hematology Date announced: 2014-09-02 Type: IPO To be raised: Up to $60 million Shares: 5 million Price: $10-$12 Underwriters: …

    Published on 9/8/2014
  • Biocartis completes venture financing

    Biocartis S.A., Lausanne, Switzerland Business: Diagnostic Date completed: 2014-09-04 Type: Venture financing Raised: EUR64.5 million ($84.7 million) Investors: Johnson & Johnson Development Corp.; Hitachi Chemical Corp…

    Published on 9/8/2014
  • Clearside Biomedical completes venture financing

    Clearside Biomedical Inc., Alpharetta, Ga. Business: Ophthalmic, Drug delivery Date completed: 2014-09-02 Type: Venture financing Raised: $16 million Investors: RusnanoMedInvest; Hatteras Venture Partners; Santen …

    Published on 9/8/2014
  • Clovis completes private placement of senior convertible notes

    Clovis Oncology Inc. (NASDAQ:CLVS), Boulder, Colo. Business: Cancer, Diagnostic Date completed: 2014-09-03 Type: Private placement of senior convertible notes Raised: $250 million Shares outstanding prior: 34 million …

    Published on 9/8/2014
  • Depomed completes private placement of senior convertible notes

    Depomed Inc. (NASDAQ:DEPO), Menlo Park, Calif. Business: Endocrine/Metabolic, Neurology, Drug delivery Date completed: 2014-09-04 Type: Private placement of senior convertible notes Raised: $300 million Shares …

    Published on 9/8/2014
  • Fractyl completes venture financing

    Fractyl Laboratories Inc., Waltham, Mass. Business: Endocrine/Metabolic Date completed: 2014-09-04 Type: Venture financing Raised: $40 million Investors: Mithril Capital Management; General Catalyst Partners; Bessemer …

    Published on 9/8/2014
  • GC-Rise completes venture financing

    GC-Rise Pharmaceutical Co. Ltd., Beijing, China Business: Genitourinary, Autoimmune, Infectious Date completed: 2014-09-02 Type: Venture financing Raised: Not disclosed Investor: OrbiMed Advisors Note: GC-Rise secured $…

    Published on 9/8/2014
  • HTG Molecular Diagnostics completes venture financing

    HTG Molecular Diagnostics Inc., Tucson, Ariz. Business: Genomics, Supply/Service, Diagnostic Date completed: 2014-08-29 Type: Venture financing Raised: $11 million Investors: Silicon Valley Bank; Oxford Finance Note: …

    Published on 9/8/2014
  • Microbix completes private placement of units

    Microbix Biosystems Inc. (TSX:MBX), Mississauga, Ontario Business: Generics, Infectious, Supply/Service Date completed: 2014-08-29 Type: Private placement of units Raised: C$777,731 ($715,979) Units: 2 million Price: C$…

    Published on 9/8/2014
  • MyCartis completes venture financing

    MyCartis, Lausanne, Switzerland Business: Diagnostic Date completed: 2014-09-04 Type: Venture financing Raised: EUR15 million ($19.7 million) Investors: RMM; Valiance; Biover II

    Published on 9/8/2014
  • Nabsys completes venture financing

    Nabsys Inc., Providence, R.I. Business: Genomics Date completed: 2014-08-29 Type: Venture financing Raised: $25.5 million Note: The company raised $25.5 million, according to an SEC filing.

    Published on 9/8/2014
  • Propeller Health completes venture financing

    Propeller Health, Madison, Wis. Business: Pulmonary, Inflammation Date completed: 2014-09-04 Type: Venture financing Raised: $14.5 million Investors: Safeguard Scientifics; The Social+Capital Partnership

    Published on 9/8/2014
  • Veloxis Pharmaceuticals completes warrant exercise

    Veloxis Pharmaceuticals A/S (CSE:VELO), Horsholm, Denmark Business: Endocrine/Metabolic, Transplant, Drug delivery Date completed: 2014-09-01 Type: Warrant exercise Raised: DKK304,004 ($53,596) Shares: 470,031 Shares …

    Published on 9/8/2014
  • Ablynx financial update

    Ablynx N.V. (Euronext:ABLX), Ghent, Belgium Business: Antibodies Date announced: 2014-09-05 Note: Ablynx is establishing a level I ADR program on the OTC market. Each ADR will represent one ordinary share. JPMorgan is …

    Published on 9/8/2014
  • Cellular Dynamics financial update

    Cellular Dynamics International Inc. (NASDAQ:ICEL), Madison, Wis. Business: ADMET, Supply/Service Date announced: 2014-09-02 Note: Cellular Dynamics filed a shelf registration covering the sale of up to $90 million of …

    Published on 9/8/2014
  • Chiesi Ventures financial update

    Chiesi Ventures, Boston, Mass. Business: Finance Date announced: 2014-09-02 Note: Chiesi Farmaceutici S.p.A. (Parma, Italy) and A. M. Pappas & Associates launched a new VC firm, Chiesi Ventures, to invest in rare and …

    Published on 9/8/2014

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993